ABBV vs VTRS
By Alex · Tickerpine
AbbVie Inc. vs Viatris Inc., side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | ABBV | VTRS |
|---|---|---|
| Price | $253.35 | $16.33 |
| Market cap | $447.62B | $19.02B |
| P/E ratio | 123.6 | — |
| ROE | — | -1.96% |
| Profit margin | 5.79% | -2.04% |
| Revenue growth | 12.40% | 8.10% |
| Dividend yield | 2.73% | 2.94% |
| Beta | 0.31 | 0.90 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
ABBV vs VTRS in plain English
- ABBV is the bigger company — about 23.5× the market cap of VTRS.
- ABBV is growing revenue faster (12% vs 8%).
- VTRS has the higher dividend yield (2.94% vs 2.73%).
How would $1,000 have done in each?
ABBV return calculator
See what $1,000 in AbbVie Inc. would be worth today.
VTRS return calculator
See what $1,000 in Viatris Inc. would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.